JessicaCassaraHochbergMD

Pediatric Hematology & Oncology • Valhalla, NY

Assistant Professor, Pediatrics, New York Medical College

Join to view full profile

Dr. Hochberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hochberg's full profile

Already have an account?

Office
19 Skyline Drive
Office 1N-D12
Valhalla, NY 10595
Phone+1 914-493-7997

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2006 - 2009
UMass Chan Medical SchoolResidency, Pediatrics, 2003 - 2006
University of Massachusetts Medical SchoolClass of 2003

Certifications & Licensure

NY State Medical License 2006 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients Start of enrollment: 2014 Mar 01
Active, not recruiting
Phase 1, Phase 2
Roles: Contact
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL Start of enrollment: 2015 Aug 21
Recruiting
Phase 2
Roles: Contact
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma Start of enrollment: 2023 Aug 24
Recruiting
Phase 3
Roles: Contact

Publications & Presentations

PubMed

5 citations
Diagnosis and management of Hodgkin lymphoma in children, adolescents, and young adults.
Jennifer A Belsky, Jessica Hochberg, Lisa Giulino-Roth
Best Practice & Research. Clinical Haematology. 2023-03-01
7 citations
Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin's lymphoma: a phase II,...
Jessica Hochberg, Jaclyn Basso, Qiuhu Shi, Liana Klejmont, Allyson Flower
Journal for Immunotherapy of Cancer. 2022-05-01
17 citations
Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy
Janet Ayello, Jessica Hochberg, Allyson Flower, Yaya Chu, Laxmi V. Baxi
Experimental Hematology. 2017-02-01

Abstracts/Posters

Polatuzumab Vedotin, an Antibody-Drug Conjugate Targeting CD79b, Is a Highly Active Agent Against Burkitt Lymphoma and Primary Mediastinal B-Cell Lymphoma
Jessica C. Hochberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Phase II results of mitoxantrone in combination with clofarabine in children with relapsed/refractory acute leukemia.
2019 ASCO Annual Meeting - 6/1/2019

Professional Memberships

American Society of Hematology - ASH
Member
American Society of Pediatric Hematology and Oncology - ASPHO
Member